Product
mDCF
1 clinical trial
1 indication
Indication
Anal CancerClinical trial
A Non-comparative Randomized 2:1 Phase II Study of Docetaxel, Cisplatin, and 5-fluorouracil in Combination or Not With Atezolizumab in Patients With Metastatic or Unresectable Locally Advanced Squamous Cell Anal CarcinomaStatus: Active (not recruiting), Estimated PCD: 2023-02-07